Skip to main content

Table 5 Mean (± SD) cTnI-value (ng/mL) in the Pimobendan- and placebo-group before and after exercise

From: Effect of Pimobendan on NT-proBNP and c troponin I before and after a submaximal exercise test in dogs with preclinical mitral valve disease without cardiomegaly – a randomised, double-blinded trial

cTnI Pimobendan-group Placebo-group
before exercise after exercise before exercise after exercise
day 0 0.022 (± 0.037) 0.051 (± 0.041) 0.1 (± 0.014) 0.116 (± 0.015)
day 90 0.039 (± 0.032) 0.048 (± 0.038) 0.049 (± 0.037) 0.057 (± 0.041)
day 180 0.038 (± 0.028) 0.041 (± 0.036) 0.051 (± 0.048) 0.068 (± 0.065)